A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis.
Booijink R, Salgado-Polo F, Jamieson C, Perrakis A, Bansal R.
EMBO Molecular Medicine. 2022
January 17, 2023
A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis.